Methodology

All entries for: Tenaya Therapeutics Inc.

April 17, 2026

Tenaya Therapeutics Inc.

Orphan Drug Designation

treatment of Duchenne muscular dystrophy

Disease Area: Rare Diseases
Source
Scroll to Top